Zusammenfassung
Lokal nichtresektable hiläre Cholangiokarzinome können durch Lebertransplantation kurativ therapiert werden. Die ursprünglich schlechten Ergebnisse nach Transplantation haben sich durch die Etablierung neoadjuvanter Therapieprotokolle und veränderte Strategien in der immunsuppressiven Therapie deutlich verbessert, sodass perihiläre Cholangiokarzinome nun wieder als Transplantationsindikation anerkannt werden. Geeignete Patienten sollten streng selektioniert werden. Die vorliegende Arbeit fasst den aktuellen Stand, Empfehlungen und die Ergebnisse der Lebertransplantation bei diesen Patienten zusammen.
Abstract
Local non-resectable, hilar cholangiocarcinoma can be cured by performing a liver transplantation. The initially poor results after transplantation have significantly improved since neoadjuvant therapy protocols have been established. Therefore, hilar cholangiocarcinoma is now an accepted indication for liver transplantation in selected patients. This article summarizes the current state, recommendations and results of liver transplantation for these patients.
Literatur
Seehofer D, Thelen A, Neumann UP et al (2009) Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl 15:1499–1507
Starzl TE, Porter KA, Putnam CW (1997) Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet 142:487–505
Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125
Broomé U, Löfberg R, Veress B, Eriksson LS (1995) Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22:1404–1408
Karlsen TH, Schrumpf E, Boberg KM (2010) Primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 24:655–666
Blechacz BRA, Gores GJ (2008) Cholangiocarcinoma. Clin Liver Dis 12:131–150
De Kerckhove L, De Meyer M, Verbaandert C et al (2006) The place of liver transplantation in Caroli’s disease and syndrome. Transpl Int 19:381–388
Ulrich F, Pratschke J, Pascher A (2008) Long-term outcome of liver resection and transplantation for caroli disease and syndrome. Ann Surg 247:357–364
Jarnagin WR, Fong Y, DeMatteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–519
Deoliveira ML, Schulick RD, Nimura Y et al (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53:1363–1371
Cucchetti A, Vitale A, Gaudio MD et al (2010) Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 10:619–627
Zhang Y, Uchida M, Abe T et al (1999) Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 23:670
Manfredi R, Barbaro B, Masselli G et al (2004) Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 24:155–164
Rösch T, Meining A, Frühmorgen S et al (2002) A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 55:870–876
Kato T, Tsukamoto E, Kuge Y et al (2002) Clinical role of 18 F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 29:1047–1054
Breitenstein S, Apestegui C, Clavien PA (2008) Positron emission tomography (PET) for cholangiocarcinoma. HPB (Oxford) 10:120–121
Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314
Heimbach JK, Gores GJ, Haddock MG et al (2006) Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82:1703–1707
Fan L, He F, Liu H et al (2011) CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 11:320
Boonjaraspinyo S, Boonmars T, Kaewkes S et al (2011) Down-regulated expression of hsp70 in correlation with clinicopathology of cholangiocarcinoma. Pathol Oncol Res 13 [Epub ahead of print]
Subimerb C, Pinlaor S, Khuntikeo N et al (2010) Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Mol Med Report 3:597–605
Tamada K, Ushio J, Sugano K (2011) Endoscopic diagnosis of extrahepatic bile duct carcinoma: advances and current limitations. World J Clin Oncol 2:203–216
Heimbach JK, Sanchez W, Rosen CB, Gores GJ (2011) Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford) 3:356–360
Hong JC, Petrowsky H, Kaldas FM et al (2011) Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg 212:514–21
Baere T de, Denys A, Madoff DC (2007) Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol 10:67–78
Makuuchi M, Donadon M, Torzilli G (2008) Hepatic resection for hepatocellular carcinoma in cirrhosis. Ann Ital Chir 79:111–115
Stockmann M, Lock JF, Malinowski M et al (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12:139–146
Neuhaus P, Thelen A, Jonas S et al (2011) Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol [Epub ahead of print]
Bundesärztekammer (2010) Bundesärztekammer – Richtlinien zur Transplantationsmedizin. Bundesarztekammer
Schlitt HJ, Loss M, Scherer MN et al (2011) Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres. Z Gastroenterol 49:30–38
Biggins SW, Bambha K (2006) MELD-based liver allocation: who is underserved? Semin Liver Dis 26:211–220
Gores GJ, Gish RG, Sudan D, Rosen CB (2006) MELD exception study group. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 12(Suppl 3):95–97
Pinson CW, Moore DE (2003) Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) 5:203–205
Jeyarajah DR, Klintmalm GB (1998) Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg 5:48–51
Robles R, Figueras J, Turrión VS et al (2004) Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 239:265–271
Heimbach JK, Gores GJ, Haddock MG et al (2004) Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24:201–207
Mantel HTJ, Rosen CB, Heimbach JK et al (2007) Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 10:1372–1381
Grossman EJ, Millis JM (2010) Liver transplantation for non-hepatocellular carcinoma malignancy: indications, limitations, and analysis of the current literature. Liver Transpl 8:930–942
Settmacher U, Götz M, Rahmel A et al (2011) Living donor liver transplantation in adults in the MELD era in Germany – a multi-center retrospective analysis. Transpl Int 24:904–911
Jonas S, Mittler J, Pascher A et al (2005) Extended indications in living-donor liver transplantation: bile duct cancer. Transplantation 80(Suppl 1):101–104
Neuhaus P, Jonas S et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230:808–819
Starzl TE, Todo S, Tzakis A et al (1989) Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 210:374–386
Jonas S, Kling N, Guckelberger O et al (1998) Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-terms results. Transpl Int 11(Suppl 1):206–208
Rea DJ, Heimbach JK, Rosen CB et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242:451
Wu Y, Johlin FC, Rayhill SC et al (2008) Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl 3:279–286
Soejima Y, Ueda S, Sanefuji K et al (2008) Sequential pancreaticoduodenectomy after living donor liver transplantation for cholangiocarcinoma. Am J Transplant 10:2158–2162
Alessiani M, Tzakis A, Todo S et al (1995) Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1801:1–9
Farmer DG, Shaked A, Colonna JO et al (1993) Radical resection combined with liver transplantation for foregut tumors. Am Surg 59:806–812
Rosen CB, Heimbach JK, Gores GJ (2010) Liver transplantation for cholangiocarcinoma. Transpl Int 23:692–697
Heimbach JK (2008) Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol 24:384–388
Sotiropoulos GC, Lang H, Niebel W et al (2004) 10-year tumor-free survival after intraoperative radiation therapy and secondary liver transplantation for hilar cholangiocarcinoma. Transplantation 77:1625
Gu J, Bai J, Shi X et al (2011) Efficacy and safety of liver transplantation for patients with cholangiocarcinoma: a systematic review and meta-analysis. Int J Cancer [Epub ahead of print]
Rizell M, Andersson M, Cahlin C et al (2008) Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer. Int J Clin Oncol 13:66–70
Castroagudín JF, Molina E, Tomé S et al (2009) Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence. Transplant Proc 41:1003–1004
Shimoda M (2001) Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 7:1023–1033
Meyer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69:1633–1637
Soderdahl G, Barkholt L, Hentschke P et al (2003) Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans. Transplantation 75:1061–1066
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rauchfuß, F., Uteß, F., Schüle, S. et al. Lebertransplantation beim hilären Cholangiokarzinom. Chirurg 83, 229–237 (2012). https://doi.org/10.1007/s00104-011-2178-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-011-2178-5